ArticleClinical pharmacology and therapeutics2026
Composite Endpoints in Contemporary Cardiovascular Trials: Trends in Phase 3 Trials and Key Issues in Regulatory Review.
Hiromi Sugano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.